There have been numerous presentations and publications on our technology and on compounds developed using it. Publications related to our pipeline are published below.
SEE FULL PRESCRIBING INFORMATION, INCLUDING BOXED WARNING
ImmunoGen’s investigational products have not been approved by the U.S. Food and Drug Administration or other regulatory authorities. The safety and efficacy of investigational products have not been established.
ABBVIE TO ACQUIRE IMMUNOGEN
Learn more about the proposed acquisition here.